Sign in
CompletedNo phase

Ketone Supplementation in Eating Disorders

Key facts

Who runs it
University of California, San Diego
Where
San Diego, United StatesSee the site
Trial code
Status
Completed
People taking part
38 people enrolled
Started
13 Oct 2022
Ended
6 Jul 2026
Type of study
Interventional
Treatments tested
  • Kenetik Ketone Drink
Record updated
3 August 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Must currently meet DSM-5 criteria for Anorexia Nervosa, Bulimia Nervosa, or OSFED Anorexia or Bulimia Nervosa based on the MINI diagnostic interview
  • Be medically stable as assessed by a comprehensive medical and behavioral evaluation conducted by a study physician
  • English as primary spoken language
  • Ability to respond to EMA questions up to 6x per day within 60 minutes of receiving the message

Who cannot take part

  • Psychotic illness/other organic brain syndromes, dementia, somatization disorders or conversion disorders
  • Physical conditions (e.g., diabetes mellitus, pregnancy) known to influence eating or weight
  • Medical conditions associated with ketoacidosis: type 1 diabetes mellitus, acute pancreatitis, alcoholic gastritis, peptic ulcer disease, hepatitis or Boerhaave syndrome (esophageal rupture)
  • History of significant head trauma
  • Indication of intellectual disability or autism spectrum disorder
  • Known allergy to any of the KenetikR drink components: D-beta-hydroxybutyric acid (D-BHB), Stevia, Monkfruit, Potassium Bicarbonate, Sodium Bicarbonate Potassium Sorbate or Taste Task Solutions: Sucrose, Potassium Chloride, Sodium bicarbonate
  • Current substance abuse or dependence in the past 3 months

Where in United States

  • University of California San DiegoSan Diego, United States

About the trial

What the trial wants to find out

This study will investigate the effects of ketone supplementation on eating behavior including drive to binge eat or restrict, mood and anxiety in individuals with anorexia or bulimia nervosa. In addition, the investigators will contrast the effects of active ketone supplementation versus placebo on electroencephalogram (EEG) measurement. All subjects enrolled in the study will undergo EEG on two consecutive days at the beginning of the study, after active ketone supplementation or placebo drink, matched in taste to the ketone drink. Days will be randomized. Thereafter, all subjects will take the ketone supplementation drink for two weeks, twice daily.

The group in the trial

  • Ketone SupplementationTreatment being tested

    Subjects will ingest 2 daily doses of Kenetik ketone drink supplementation for 14 days.

    Treatment: Kenetik Ketone Drink

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Starving for Energy - A Pilot Study to Test Ketone Derived Energy in Eating Disorders
Record updated
3 August 2026